CWM
KRTX

Cornerstone Wealth Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Cornerstone Wealth Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,805
Closed -$228K – 468
2022
Q2 		$228K Sell
1,805
-50
-3% -$5.75K 0.03% 400
2022
Q1 		$235K Sell
1,855
-100
-5% -$11.3K 0.02% 418
2021
Q4 		$272K Sell
1,955
-270
-12% -$34.9K 0.03% 416
2021
Q3 		$272K Hold
2,225
– – 0.03% 371
2021
Q2 		$254K Sell
2,225
-2,220
-50% -$260K 0.03% 395
2021
Q1 		$534K Sell
4,445
-25
-0.6% -$2.83K 0.06% 263
2020
Q4 		$454K Buy
+4,470
New +$414K 0.06% 265

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Cornerstone Wealth Management's KRTX Position: Q3 2022 in Review

Cornerstone Wealth Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2022, closing a stake of 1,805 shares — an estimated $228K sold.

Cornerstone Wealth Management first reported a position in KRTX in Q4 2020 and held it in 7 quarters. The position peaked at $534K in Q1 2021. 257 funds tracked by Wall St. Rank hold KRTX as of Q3 2022.

  • Cornerstone Wealth Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Cornerstone Wealth Management sold 1,805 Karuna Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $228K.
  • Cornerstone Wealth Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • Cornerstone Wealth Management's Karuna Therapeutics, Inc. Common Stock position peaked at $534K in Q1 2021.
  • 257 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Cornerstone Wealth Management's 13F filing for Q3 2022, filed 14 Oct 2022.